Stasinos Chr. Sikalias · The science of compounding

Ethanol for Disinfection JP

CGR-JP-007 · MHLW — JP XVIII: Ethanol for Disinfection JP

For local reviewCGR-JP-007Japan

Documented bibliographic addition; requires local scientific approval before use as a master formulation record.

Dosage formSolution for external pharmaceutical use
Reference batch1000 mL
Monograph version5.0
Source packagev5

Source formula

IngredientSource quantity
Ethanol JP, 95.1–96.9% v/v at 15°C830 mL
Purified waterq.s. ad 1000 mL

Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.

Description

Documented in source

Clear, colourless, volatile, flammable liquid, miscible with water.

References: [1]

Use and action

Partial evidence

Ethanol preparation for disinfection as named by JP. This monograph does not prescribe a dose, contact time or efficacy against a specific microorganism.

References: [1]

Specifications

Documented in source

Final ethanol 76.9–81.4% v/v at 15°C. Relative density d15/15: 0.86027–0.87264. Clear, colourless solution. Comply with prescribed purity tests.

References: [1]

Light

Documented in source

The specific monograph requires light protection.

References: [1]

Air

Partial evidence

Ethanol generates vapour; limit time in open vessels. Evaporation can change composition (editorial process assessment).

References: [5]

Water and solubility

Documented in source

Miscible with water. Adding water changes strength; final volume adjustment and density verification are required.

References: [1]

Humidity

Not established

No specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.

References: [1]

Temperature

Not established

No specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.

References: [1]

pH and related incompatibilities

Not established

No specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.

References: [1]

Other incompatibilities

Partial evidence

Ethanol is incompatible with strong oxidants.

References: [5]

Ingredient-specific information

Partial evidence

Exact identities: Αιθανόλη JP, 95,1–96,9% v/v στους 15°C / Ethanol JP, 95.1–96.9% v/v at 15°C; Κεκαθαρμένο ύδωρ / Purified water. Use pharmacopoeial raw materials of the referenced edition, with CoA verification. Do not arbitrarily change salt, hydration state or strength. Record the actual q.s. amount in the batch.

References: [1]

Compounding conditions

Editorial checklist

JP provides no specific numerical room limits for this formula. Define a local SOP covering suitable clean conditions, temperature control and contamination prevention. This is an editorial checklist.

References: [1] · [2]

Personal protective equipment

Partial evidence

Clean protective clothing and head covering under AEMPS PN/L/PG/002/00. Use suitable gloves where contact is possible and respiratory/eye protection where powder handling requires it. Exact glove material, ventilation and respiratory protection must follow the SDS and local exposure assessment.

References: [4]

Risks and precautions

Partial evidence

Flammable vapour. Assess ventilation, ignition sources and the amount of solvent handled by the laboratory.
Ethanol: flammable vapour; control ignition sources and provide suitable ventilation. Final classification depends on concentration/mixture.

References: [1] · [5]

BUD rationale

Not established

The specific monograph provides no finished-product beyond-use period/BUD. No duration is assigned by assumption. Suitable stability evidence and responsible-pharmacist approval are required before release.

References: [1]

Bases and dependencies

Documented in source

No separate compound base is required in the explicit formula.

References: [1]

Equipment

Editorial checklist

Balance with suitable resolution, mortar/spatula, suitable mixing vessels and final container. Add volumetric equipment for mL, a controlled water bath where melting is specified and a suitable filter where required. Analytical equipment follows the QC methods.

References: [1] · [2]

Preparation procedure

Partial evidence

1. Verify JP-grade starting ethanol containing 95.1–96.9% v/v at 15°C.
2. Measure 830 mL and add purified water.
3. Mix and make up to a final volume of 1000 mL with water. Temperature equilibration before final volume adjustment is a local control for contraction/heating during mixing. Verify final strength by the official method.

References: [1] · [2]

Observations

Partial evidence

830 mL of JP Ethanol does not mean 83% absolute ethanol. Do not substitute the same volume of anhydrous ethanol. The 24-month period in the adjacent Ethanol/Anhydrous Ethanol monograph is not transferred here.

References: [1]

Packaging

Partial evidence

Tight, light-resistant container.

References: [1]

Labelling

editorial_specimen

Ethanol for Disinfection JP
Quantity: _____ · Batch: _____ · Prepared: _____ · Use by: _____
External use only. Storage: Keep tightly closed and protected from light. Control ignition sources because of ethanol. The specific monograph gives no numerical storage temperature.
Patient/directions or laboratory use: _____ · Pharmacy/telephone: _____
Flammable. Keep away from flames. Do not swallow.
Specimen for pharmacist adaptation; not a final approved label.

References: [1] · [5]

Quality control

Partial evidence

Use JP 2.56 relative density to verify concentration. Identification uses the two chemical reactions in the specific monograph. Purity follows Ethanol tests (clarity, acidity/alkalinity, volatile impurities by GC, evaporation residue), with a specific final-solution UV test: 5 cm cell, water blank; A240 ≤0.40, A250–260 ≤0.30, A270–340 ≤0.10 and a smooth curve over 235–340 nm. Execution requires the full referenced text.

References: [1] · [2]

Storage

Partial evidence

Keep tightly closed and protected from light. Control ignition sources because of ethanol. The specific monograph gives no numerical storage temperature.

References: [1] · [5]

Dispensing and directions

Partial evidence

Label as a disinfectant preparation; not for drinking. Establish the permitted application and contact time separately. Do not infer marketing authorisation or a specific antimicrobial spectrum from this monograph alone.

References: [1]

Sources and traceability

  1. MHLW — JP XVIII: Ethanol for Disinfection JP

    2021 · JP XVIII (2021), printed pp. 966–967; starting Ethanol pp. 964–965 · A1 official pharmacopoeia

    Review date reported in supplied metadata: 2026-09-10

  2. MHLW — JP XVIII, General Rules for Preparations

    2021 · 11-4 Ointments and 11-2 Cutaneous liquids, printed p. 20; Other Preparations 3 Spirits, p. 22; General Notices · A1 official pharmacopoeia

    Review date reported in supplied metadata: 2026-09-10

  3. PN/L/FF/007/00 ELABORACIÓN DE SOLUCIONES

    PN/L/FF/007/00 · §4.3 environment; §4.4 method; §4.6 controls · A2 official technical guidance

    Review date reported in supplied metadata: 2026-09-10

  4. PN/L/PG/002/00 INDUMENTARIA

    PN/L/PG/002/00 · Clothing and protective equipment · A2 official technical guidance

    Review date reported in supplied metadata: 2026-09-10

  5. niosh_ethanol

    Official agency page · Raw-material properties, handling and incompatibilities · A2 official technical guidance

    Review date reported in supplied metadata: 2026-09-10

  6. AEMPS — Aviso legal

    Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence

    Review date reported in supplied metadata: 2026-09-10

  7. BOE — Real Decreto 1495/2011, artículos 7–10 y anexo

    Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence

    Review date reported in supplied metadata: 2026-09-10

  8. MHLW — Copyright and Public Data License policy

    Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence

    Review date reported in supplied metadata: 2026-09-10

  9. Digital Agency — Public Data License 1.0

    Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence

    Review date reported in supplied metadata: 2026-09-10

  10. PMDA — JP XVIII supplements and errata index

    Supplement I 2022; II 2024; base errata March 2026 · Selected entries checked; no change to these four compositions identified · A1 official edition control

    Review date reported in supplied metadata: 2026-09-10

Provenance and reuse

Source: Ministry of Health, Labour and Welfare, Japan, Japanese Pharmacopoeia XVIII, English edition 2021. Reuse under Public Data License 1.0 through the MHLW policy, with source attribution and changes identified. Greek translation, English summary/restructuring and editorial additions: Greek Formulary Sikalias, Stasinos Chr. Sikalias, compounding.gr. This is not an official translation or MHLW endorsement. The Japanese original prevails if it differs from the official English rendering. No logos or specially restricted third-party material are used. Supplementary AEMPS/CDC information is attributed separately. CDC/NIOSH sources are freely available from CDC; brief technical paraphrases imply no CDC endorsement.

SHA-256 of the supplied PDF: dd330e4c8c124359a8a5754069f91d59f44d77735de3177bff98fb2e64be7bc1